HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

John F Kuttesch Selected Research

John F Kuttesch Research Topics

Disease

8Neoplasms (Cancer)
10/2021 - 01/2002
2Brain Neoplasms (Brain Tumor)
07/2019 - 10/2003
2Astrocytoma (Pilocytic Astrocytoma)
10/2003 - 10/2002
1Rhabdomyosarcoma
01/2023
1Alveolar Rhabdomyosarcoma
01/2023
1Embryonal Rhabdomyosarcoma
01/2023
1Sepsis (Septicemia)
10/2019
1Hemophagocytic Lymphohistiocytosis (Hemophagocytic Syndrome)
10/2019
1Fever (Fevers)
10/2019
1Hyperferritinemia
10/2019
1Sarcoma (Soft Tissue Sarcoma)
10/2009
1Non-Hodgkin Lymphoma (Lymphosarcoma)
05/2006
1Hodgkin Disease (Hodgkin's Disease)
05/2006
1Medulloblastoma
10/2003
1Ependymoma
10/2003
1Hypopituitarism (Sheehan's Syndrome)
11/2002
1Diabetes Insipidus
11/2002
1Obesity
11/2002
1Glioblastoma (Glioblastoma Multiforme)
10/2002
1Glioma (Gliomas)
10/2002

Drug/Important Bio-Agent (IBA)

2Vinorelbine (Navelbine)FDA LinkGeneric
01/2023 - 10/2009
2AlkaloidsIBA
01/2023 - 10/2009
2Carboplatin (JM8)FDA LinkGeneric
11/2004 - 01/2002
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
01/2023
1Ferritins (Ferritin)IBA
10/2019
1Ribonuclease III (RNase III)IBA
07/2014
1Thalidomide (Thalomid)FDA Link
11/2004
1Thyroxine (Levothyroxine)FDA LinkGeneric
11/2002
1Triiodothyronine (Liothyronine)FDA LinkGeneric
11/2002
1Alkylating AgentsIBA
10/2002
1Temozolomide (Temodar)FDA LinkGeneric
10/2002
1Topotecan (Hycamtin)FDA LinkGeneric
01/2002
1trioctyl phosphine oxide (TOPO)IBA
01/2002
1Antineoplastic Agents (Antineoplastics)IBA
01/2002

Therapy/Procedure

4Therapeutics
10/2021 - 01/2002
3Drug Therapy (Chemotherapy)
01/2023 - 01/2002
2Radiotherapy
10/2003 - 10/2002
1Secondary Prevention
10/2019
1Aftercare (After-Treatment)
07/2019